Clinical Trials in Garra, Australian Capital Territory

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

NCT ID: NCT04973605

This clinical trial is studying a new treatment called BGB-11417 for patients with relapsed or refractory multiple myeloma, which is a type of blood cancer. The trial has two parts: the first part ...